Nebenwirkungen · Tepadina
TEPADINA 15 mg powder for concentrate for solution for infusion TEPADINA 100 mg powder for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 12
HOS-210408 · Präparat HOS-154509
Nervous system disorders Headache Ataxia Leukoencephalopathy Encephalopathy Convulsion Cerebral haemorrhage Memory impairment Paresis Ear and labyrinth disorders Hearing impaired Cardiac disorders Cardiac arrest Cardiovascular insufficiency Cardiac failure Vascular disorders Haemorrhage Hypertension Respiratory, thoracic and Pneumonitis Idiopathic Pulmonary arterial mediastinal disorders pneumonia hypertension syndrome Pulmunary haemorrage Pulmonary oedema Epistaxis Hypoxia Respiratory arrest Gastrointestinal disorders Nausea Enteritis Stomatitis Intestinal Vomiting obstruction Diarrhoea Abdominal pain Hepatobiliary disorders Venoocclusive Liver failure liver disease Skin and subcutaneous tissue Rash Severe toxic skin disorders Erythema reactions including Desquamation cases of Stevens- Pigmentation Johnson syndrome disorder and toxic epidermal necrolysis Musculoskeletal and connective Growth tissue disorders retardation Renal and urinary disorders Bladder disorders Renal failure Cystitis haemorrhagic General disorders and Pyrexia administration site conditions Mucosal inflammation Pain Multi-organ failure
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-02-24T14:00:00Z · SHA-256 42c8bab87a55159cb982d55f577a064273549ce149f75b75dbf4d5650be413bc · Passage 87ede36a39d084492f988f834b4ba2f70ff0b5eb078bdc3039d66ddb427e4304 · Zeichen 9781–12630 im Abschnitt